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Abstract Guanylate-binding proteins (GBPs) were originally 
described as proteins that are strongly induced by interferons and 
are capable of binding to agarose-immobilized guanine nucleo- 
tides, hGBP1, the first of two members of this protein family in 
humans, was recently shown to represent a novel type of GTPase 
that hydrolyzes GTP predominantly to GMP. We now report 
that purified recombinant hGBP2 also hydrolyzes GTP very 
efficiently, although GDP rather than GMP was the major 
reaction product. The biochemical parameters of this reaction 
were as follows: Krn = 313 lEVI, turnover number = 22 min -1. 
Both hGBP1 and hGBP2 failed to hydrolyze GDP, however, 
GDP was an effective inhibitor of the hGBP2- but not the 
hGBPl-catalyzed GTP hydrolysis reaction. Thus, hGBP1 and 
hGBP2 have similar biochemical properties, but show pro- 
nounced differences in product specificity. 
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1. Introduction 
The interferon-induced guanylate-binding proteins (GBPs) 
were originally discovered as a result of their ability to bind to 
agarose-immobilized guanine nucleotides [1,2]. A characteris- 
tic feature of GBPs is that they lack a tripartite GTP-binding 
consensus motif: the classical third element of this motif  (N/ 
TXPG) [3] is missing in human [4], mouse [4], rat [5] and 
chicken [6] GBPs. The physiological role of the GBPs in the 
interferon response is unknown: mouse strains which fail to 
express GBP1, but which express other GBP family members, 
are healthy and do not show enhanced susceptibility to viral 
and other pathogens [7-9]. 
Two co-expressed GBPs were identified in humans, desig- 
nated hGBP1 and hGBP2 [4], both of which have molecular 
masses of about 67 000 Da. Due to a C-terminal CaaX motif, 
recombinant hGBP1 can be isoprenylated in vitro [10], sug- 
gesting that it is a membrane-associated protein. We have 
recently shown that hGBP1 is a novel type of GTPase that 
converts GTP mainly to GMP, presumably via two consecu- 
tive cleavages of a single phosphate group [10]. The Km for 
this reaction is high, and purified hGBP1 can perform multi- 
ple cycles of GTP hydroloysis in the absence of accessory 
factors [10]. Here, we report that hGBP2 is a GTPase that 
resembles hGBP1 in many respects. However, GDP is the 
major reaction product of the hGBP2-catalysed hydrolysis 
reaction. 
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2. Materials and methods 
2.1. Determination of the 5'-proximal sequence of the hGBP-2 mRNA 
The nucleotide sequence near the 5' end of the hGBP2 mRNA was 
determined by the 5' RACE procedure according to the manufac- 
turer's protocol (Gibco-BRL). For cDNA synthesis we used the pri- 
mer 5'TTTGCCTTGATTCGATC3' which corresponds to positions 
449~,33 of the previously isolated hGBP-2 cDNA clone [4] and poly- 
(A) + RNA from HaCat cells treated with 1000 units per ml each of 
interferon-'y and interferon-c~2a. After C-tailing with terminal deoxy- 
nucleotide transferase, the cDNA was amplified by PCR using the 
RACE anchor primer and the primer 5'GTTGGTCCATGGCCT- 
GCTGGTTGATGGTTCCC3' which corresponds to positions 410- 
379 of hGBP2 cDNA [4]. The PCR products were cloned into the TA 
cloning vector pCR (InVitrogen, San Diego) and the inserts of indi- 
vidual clones were sequenced. 
2.2. Expression constructs 
The plasmid pHis-hGbpl, which permits high-level expression of 
histidine-tagged hGBP1 in E. coli, has previously been described 
[10]. pHis-hGbp2, which codes for a histidine-tagged variant of 
hGBP2, was constructed by replacing the coding sequence of 
hGBP1 for that of hGBP2. The appropriate hGBP2 cDNA fragment 
was generated by PCR from a cDNA library derived from interferon- 
induced human fibroblasts [11] using the primer 5'ACTTAG- 
GATCCGCTCCAGAGATCAACTTG3' which carries a BamHI re- 
striction site and which corresponds to positions 160-177 of the 
RACE hGBP2 cDNA clone (Fig. 1A) and the primer 5'ATT- 
GAACGTCGACGGCAAATTTTGCTCCTTGGACT3' which car- 
ries a Sail restriction site and which corresponds to positions 1784- 
1763 of the previously characterized hGBP2 cDNA [4]. The PCR 
product was digested with BamHI and Sail and cloned into the cor- 
responding sites of pQE9. The resulting plasmid codes for a protein 
that consists of the N-terminal polypeptide Met-Arg-Glu-Ser-(His)6- 
Gly-Ser fused to the alanine at position 2 of the full-length GBP2 
sequence (Fig. 1B). 
2.3. Purification of recombinant GBPs from E. coli 
Histidine-tagged hGBP2 protein was enriched from the bacterial 
lysate by Ni-chelate affinity chromatography [10]. This material was 
then applied to a MonoQ FPLC chromatography column (Pharma- 
cia, Freiburg, Germany) equilibrated with buffer A (50 mM Tris-HC1 
pH 8.0, 100 mM NaC1, 10% glycerol, 1 mM DTT, 0.1% NP40), and 
bound proteins were eluted with a linear gradient of 100-1000 mM 
NaC1. hGBP2 eluted at about 300 mM NaC1. A second round of 
MonoQ chromatography was performed with the peak fraction of 
the first column. The purity of hGBP2 was more than 95%. Histi- 
dine-tagged hGBP1 was purified as described [10]. 
2.4. HPLC analysis 
Analysis of nucleotides by HPLC was performed as described [12] 
with slight modifications. Briefly, a C-18 reversed-phase column 
(0.4×25 crn filled with ODS Hypersil, 5 ~tm, Bischoff, Leonberg, 
Germany) was run at ambient emperature at a flow rate of 1 ml/ 
min in 50 mM Na-phosphate (pH 6.5) containing 0,2 mM t-butylam- 
monium bromide, 3% (v/v) acetonitrile, and 0.2 mM NaNz. In this 
system, GMP eluted at 4.8 min, GDP at 7.5 min and GTP at 10.6 
min. The absorption was measured at 252 nm with a VWM-2141 UV 
detector (Pharmacia) and the signals were quantified with a C-R5A 
integrator (Shimadzu, Kyoto, Japan). 
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2.5. Nucleotides 
Radiolabeled [tx-a2P]GTP (3000 Ci/mmol) was purchased from 
Amersham. The non-hydrolyzable nucleotide analogs guanosine 5'- 
[[~,y-thio]triphosphate (GTPyS), guanosine 5'-[~,y-imido]triphosphate 
(GMP-PNP) and adenosine 5'-[13,y-imido]triphosphate (AMP-PNP) 
were obtained from Boehringer Mannheim. GTP, GDP, GMP, 
ATP, UTP and CTP were purchased from Pharmacia. 
2.6. Assay for GTPase activity 
GTPase assays were performed with 0.02 mg/ml of either purified 
His-hGBP2 or purified His-hGBP1 [10] in buffer B (13 nM [ct- 
32P]GTP (3000 Ci/mmol), 50 mM Tris-HCl, pH 8.0, 5 mM MgC12, 
100 mM KC1, 10% glycerol, 0.1 mM DTT and 100 nM adenosine 5'- 
[~,y-imido]triphosphate)  37°C as described [10]. The concentration 
of unlabeled GTP was 100 ~tM, except where the indicated concentra- 
tions were used. At various times, the reaction was stopped by adding 
an equal volume of a stop solution containing 2 mM EDTA and 0.5% 
SDS. Samples were spotted onto polyethyleneimine-cellulose (PEI) 
thin-layer chromatography plates (MN300, Macherey und Nagel, Dti- 
ren, Germany) and resolved in buffer C (1 M acetic acid, 1 M LiCl). 
The plates were exposed to X-ray film. The signals were quantified 
with a digital autoradiograph LB286 (Berthold, Wildbad, Germany). 
To calculate specific GTPase activities, time points within the linear 
range of the hydrolysis reaction were used. To determine the Km and 
turnover number, GTPase reactions were performed under optimized 
conditions. The GTP concentrations varied from 0.1 to 2.0 mM. 
3. Results 
3.1. hGBP2 mRNA sequence 
Since the previously cloned hGBP2 cDNA was an incom- 
plete copy of the corresponding mRNA [4], we set out to 
isolate the missing part by the 5' RACE technique using 
poly(A) + RNA of IFN-7-treated HaCat  cells. Five RACE 
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Fig. l. Structure of hGBP2 at the N-terminus. (A) Nucleotide se- 
quence of the first 213 residues of a 5' RACE eDNA clone and de- 
duced N-terminal amino acid sequence of hGBP2. The C-residue at 
position 195 which was not found in the previously characterized in- 
complete hGBP2 cDNA clone [4] is marked by an asterisk. (B) Se- 
quence comparison of the N-terminal 19 amino acids of hGBP1 
and hGBP2, respectively. 
cDNA clones were sequenced. The sequence of one of these 
clones is shown in Fig. 1A (GeneBank accession no. M 
55543). A second clone had an identical sequence, except 
that it carried some addit ional nucleotides at the 5' end. 
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Fig. 2. Purification and GTPase activity of His-hGBP2. (A) Purification of histidine-tagged hGBP2 from E. coli. Samples were analysed on 
10% SDS-PAGE before (lane 1) and after (lane 2) induction of the culture with IPTG. His-hGBP2 was affinity-purified from the soluble cell 
fraction by Ni-agarose chromatography (lane 3), and subsequently oaded onto a MonoQ column. Bound material was eluted at 300 mM 
NaC1 (lane 4). Fractions with the highest purity were reapplied to MonoQ chromatography and eluted with 300 mM NaC1 (lane 5). (B) 
GTPase activity of His-hGBP2. GTPase assays were carried with either 100 ktM GTP or 100 ~tM GDP in the presence or absence of MonoQ- 
purified His-hGBP2 (0.02 ~tg/~l) for 30 min at 37°C. The reaction products were analysed by HPLC. The chromatogram was monitored at 252 
nm. The identity of the nucleotide peaks and their retention times are indicated. The peaks were integrated, and the relative concentrations of 
the various nucleotides (in percent) are given. 
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Fig. 3. Inhibition of hGBP2 and hGBP1 by various nucleotides. GTPase assays performed in the presence of (A) MonoQ-purifed His-hGBP2 
(0.02 txg/Ixl) and (B) MonoQ-purified hGBP1 (0.02 p,g/txl) and a 15-fold molar excess of the indicated nucleotides over radiolabeled GTP. Sam- 
pies were analyzed by PEI thin-layer chromatography and autoradiography. The positions of GTP, GDP and GMP are indicated. 
The other three clones had 5' truncations, but were otherwise 
identical. All RACE clones differed from the published 
hGBP2 sequence [4] by an extra C residue at position 195 
(Fig. 1A), indicating that the previously deduced sequence 
of the N-terminus of hGBP2 was incorrect. The first initiation 
codon of the new sequence at position 157 (Fig. 1A) marks 
the beginning of the hGBP2 coding region. It is located in a 
favorable context for translation initiation in eukaryotes [13] 
and is preceded by an in-frame stop codon at position 22. 
Comparison of the predicted N-termini of hGBP2 and 
hGBP1 revealed a high degree of sequence identity (Fig. 
1B). Thus, hGBP2 is composed of 591 amino acids and has 
a calculated molecular mass of 67 189 Da. 
3.2. hGBP2 is an enzyme that converts GTP to GDP and GMP 
For biochemical studies we cloned the complete coding re- 
gion of hGBP2 into the E. coli expression vector pQE9. The 
resulting construct codes for N-terminally histidine-tagged 
hGBP2, designated His-hGBP2. Histidine tagging allows for 
rapid and efficient purification of recombinant proteins from 
bacterial ysates [10]. His-hGBP2 was strongly induced in 
E. coli after induction with IPTG (Fig. 2A, lanes 1,2) and 
could be isolated from the soluble fraction of bacterial lysates 
by Ni-agarose chromatography (Fig. 2A, lane 3). Partially 
purified His-hGBP2 readily bound to MonoQ and eluted at 
about 300 mM NaC1 (Fig. 2A, lane 4). After a second round 
of MonoQ chromatography, His-hGBP2 had a purity of 
about 95% as revealed by Coomassie blue staining of the 
gel (Fig. 2A, lane 5). 
The enzymatic activity of His-hGBP2 was assayed by incu- 
bation of purified protein with 100 ~tM GTP at 37°C and 
analysis of the reaction products by HPLC. GTP was rapidly 
hydrolysed to GDP and GMP (Fig. 2B). Quantitation of the 
signals revealed that 75% of the substrate was converted to 
GDP and 11% was converted to GMP. No hydrolysis of ATP, 
CTP or UTP was observed under these conditions (data not 
shown), indicating that the observed activity of His-hGBP2 
was specific for GTP. This latter result further demonstrated 
that our hGBP2 preparation was essentially free of contam- 
inating phosphatases. His-hGBP2 produced by expressing a
second independent hGBP2 cDNA clone exhibited identical 
biochemical properties (data not shown). The Km of the His- 
hGBP2-catalysed hydrolysis of GTP was 313 IxM. The specific 
GTPase activity of our best preparation of His-hGBP2 was 
325 nmol/min per mg, corresponding to a turnover number of 
22 min -1. 
Since GMP was a reaction product, we wished to determine 
whether GDP could serve as a substrate for His-hGBP2. To 
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test this, hGBP2 was incubated with 100 gM GDP at 37°C 
and the products were analysed by HPLC. His-hGBP2 failed 
to hydrolyse GDP under these conditions (Fig. 2B). 
3.3. The apparent affinities of hGBP2 for GDP and GMP differ 
from those of  hGBP1 
His-hGBP2 and the previously characterized His-hGBP1 
[10] are both GTPases that convert GTP to GMP (Fig. 3). 
Since the product ratios differed markedly, we investigated 
whether the two enzymes have different affinities for GDP 
and GMP. We therefore performed competition experiments 
with the GTP analog GTPTS. When a 15-fold molar excess of 
GTP3,S was used, hydrolysis of GTP by either His-hGBP2 or 
His-hGBP1 was strongly inhibited (Fig. 3). GTPTS was not 
hydrolysed to GMP by either His-hGBP1 [10] or His-hGBP2 
(data not shown). The non-hydrolysable GTP analog GMP- 
PNP was a similarly potent inhibitor of His-hGBP2 (data not 
shown). Differences between hGBP1 and hGBP2 were ob- 
served when GDP was used as a competitor: GDP strongly 
inhibited the hydrolysis of GTP by His-hGBP2 (Fig. 3A, lane 
4), but had almost no inhibitory effect on His-hGBP1 (Fig. 
3B, lane 3). When GMP was used as a competitor, GTP 
hydrolysis by hGBP1 was inhibited (Fig. 3B, lane 4), whereas 
that of His-hGBP2 was not (Fig. 3A, lane 5). Thus, for both 
enzymes, the most prominent reaction products also proved to 
be the most efficient competitors. 
4. Discussion 
We have recently shown that hGBP1 is an unusual GTPase 
that hydrolyzes GTP predominantly to GMP [10]. We now 
demonstrate hat hGBP2 has similar GTPase activity but that 
in contrast to. hGBP1, the major reaction product of the 
hGBP2-catalysed hydrolysis of GTP is GDP rather than 
GMP. 
The previously cloned cDNA for hGBP2 is an incomplete 
copy of the corresponding mRNA. Using the 5' RACE pro- 
cedure, we obtained the sequence information ecessary for 
reconstruction of the hGBP2 open reading frame. Our analy- 
sis showed that the formerly characterized GBP2 cDNA clone 
carried a mutation and that the predicted N-terminal sequence 
of hGBP2 was incorrect. A cDNA encoding full-length 
hGBP2 was expressed in E. eoli as a N-terminally histidine- 
tagged protein to facilitate its purification. Highly purified 
His-hGBP2 hydrolysed GTP mainly to GDP (85-90%) and 
to a lesser extent to GMP (10-15%). Formation of GMP 
was indeed due to an intrinsic activity of hGBP2, since this 
activity co-purified with His-hGBP2 and since unrelated pro- 
teins purified under identical conditions lacked such activity 
([12] and unpublished ata), hGBP2 thus resembles the pre- 
viously characterized hGBP1 [10] by being an unconventional 
GTPase that converts GTP to GDP and GMP. However, a 
remarkable biochemical difference between hGBP1 and 
hGBP2 is that the former enzyme hydrolyzes GTP predomi- 
nantly to GMP, whereas the latter enzyme hydrolyzes this 
substrate predominantly to GDP. Accordingly, the two en- 
zymes also differ in their sensitivities to inhibition by the re- 
action products: GDP potently inhibited hGBP2 but not 
hGBP1, while GMP strongly inhibited hGBP1 but not 
hGBP2. Taken together, the biochemical properties of 
hGBP2 strikingly resemble those of the recently cloned GBP 
homolog of the chicken [6]. 
Our experiments with the second member of the human 
GBP family confirm previous results with hGBP1, which 
showed that these GTPases have unusual biochemical proper- 
ties [10], and further emphasize the unique position of the 
GBPs in the superfamily of GTPases. Unlike conventional 
GTPases, GBPs strongly bind to agarose-immobilized GTP, 
GDP or GMP [4]. Nonetheless, they bind guanine nucleotides 
only poorly in solution, as indicated by the fact that all pur- 
ified GBPs have empty nucleotide binding pockets ([10] and 
unpublished results). Presumably as a consequence of these 
properties, GBPs have characteristically high Km values for 
the GTP hydrolysis reaction and can perform multiple cycles 
of GTP hydrolysis in the absence of nucleotide xchange fac- 
tors. The most unusual property of GBPs is that they are able 
to synthesize GMP. The physiological significance of in- 
creased GMP levels resulting from the action of GBPs in 
the interferon-induced cell remains obscure. 
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